BAG-1在中耳胆脂瘤中的表达及意义
马亦飞;丁家秀;鲜志芃;何星辰;顾萍;喻国冻;
1:贵州医科大学附属医院耳鼻咽喉头颈外科
2:贵阳市第一人民医院全科医学科
摘要关键词基金项目(Foundation):作者参考文献[1]廖军，林昶．中耳胆脂瘤的可能发病机制[J]．中华耳科学杂志，2015,13(2):362-365．
[2] Jiang H,Si Y,Li Z,et al.TREM-2promotes acquired cholesteatoma-induced bone destruction by modulating TLR4signaling pathway and osteoclasts activation[J].Sci Rep,2016,6:38761．
[3] Gao J,Tang Q,Zhu X,et al.Long noncoding RNAs show differential expression profiles and display ceRNA potential in cholesteatoma pathogenesis[J].Oncol Rep,2018,39(5):2091-2100．
[4]王江，魏晓丽．胆脂瘤与增殖通路的研究进展[J]．中华耳鼻咽喉头颈外科杂志，2018,53(9):703-708．
[5] Imai R,Sato T,Iwamodo Y,et al.Osteoclasts modulate bone erosion in cholesteatoma via RANKL sigaling[J].J Assoc Res Otolaryngol,2019,20(5):449-459．
[6] Ferguson BJ,Gillespie CA,Kenan PD,et al.Mechanisms of cholesteatoma formation following stapedectomy[J].Am JOtol,1986,7(6):420-424．
[7] Papadakis ES,Barker CR,Syed H,et al.The BAG-1inhibitor,Thio-2,reverses an atypical 3D morphology driven by BAG-1Loverexpression in a MCF-10A model of ductal carcinoma in situ[J].Oncogenesis,2016,5(4):215．
[8] Huang W,Liu Z,Zhou G,et al.Magnetic gold nanoparticlemediated small interference RNA silencing Bag-1gene for colon cancer therapy[J].Oncol Rep,2016,35(2):978-984．
[9] Saleh HA,Mills RP.Classification and staging of cholesteatoma[J].Clinical Otolaryngology&Allied Sciences,1999,24(4):355-359．
[10]刘伟，殷团芳，任基浩．中耳胆脂瘤上皮细胞的抗凋亡机制[J]．国际病理科学与临床杂志，2010,30(2):181-184．
[11] Huisman MA,De Heer E,Grot JJ.Cholesteatoma epithelium is characterized by increased expression of Ki-67,p53and p2l,with minimal apoptosis[J].Acta Otolaryngol,2003,123(3):377-382．
[12] Park HR,Min SK,Min K,et al.Increased expression of p63and survivin incholesteatomas[J].Acta Otolaryngol,2009,129(3):268-272．
[13] Takayama S,Sato T,Krajewski S,et al.Cloning and functional analysis of BAG-1:a-novel Bcl-2-binding protein with anticell death activity[J].Cell,1995,80(2):279-284．
[14] Briknarova K,Takayanm S,Brive L,et al.Structural analysis of BAG-l cochaperone and its interactions with Hsc70heat shock protein[J].Nat Struct Biol,2001,8(4):349-352．
[15]王慧，李旭强，郑纪宁．凋亡抑制基因BAG-1的结构功能概述[J]．承德医学院学报，2010,27(2):201-203．
[16] Kuczkowski J,Sakowicz-Burkiewicz M,Izycka-Swieszewska E.Ex pression of the receptor activator for nuclear factor-kB ligand and osteoprotegerin in chronic otitis media[J].Am J Otolaryngol,2010,31(6):404-409．
[17] Kimachi K,Kajiya H,Nakayama S,et al.Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoelastogenesis[J].Naunyn Schmied Arch Pharmacol,2011,383(3):297-308．
[18] Takayama S,Krajewski S,Krajewska M,et al.Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1and its variants in normal tissues and tumour cell lines[J].Cancer Res,1988,58(14):3116-3131．
[19] Townsend PA,Dublin E,Hart IR,et al.BAG-1expression in human breast cancer:interrelationshp between BAG-1RNA,protein,Hsc70 expression and clinico data[J].J Pathol,2002,197(1):51-59.